Artificial Intelligence in Healthcare and Education
13 developments in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Future Journal of Pharmaceuticals and Health Sciences
This is a narrative review that raises questions about AI applications in cancer diagnosis and treatment without reporting original data, controlled comparisons, or quantified evidence of clinical outcomes.
Single-center retrospective cohort with internal validation only; machine-learning models show promising discrimination but lack external validation and prospective confirmation required to establish clinical utility.
A structured narrative review synthesizing evidence on AI across obesity management pathways, finding limited direct patient-level evidence for AI-specific effects and recommending AI as a clinical augmentation tool pending further validation.
A narrative review synthesizing AI applications across drug discovery, nanosystems delivery, and disease treatment; descriptive and exploratory rather than reporting original empirical results or clinical outcomes.
A narrative review synthesizing current evidence on AI applications in cardiovascular prevention, addressing implementation gaps and future requirements rather than reporting original trial results.
A sound cross-sectional concordance study with independent expert adjudication showing moderate physician–CDSS agreement and favourable expert validation of CDSS recommendations in discordant cases, but lacking comparative clinical effectiveness or patient outcome data.
A systematic review synthesizing fragmented evidence across 62 studies showing DHTs enable value-based cardiology care through improved adherence and monitoring, but confirming rather than establishing new practice, given heterogeneous evidence quality and only 4 RCTs (6.5%).
Journal of King Saud University - Computer and Information Sciences
A systematic literature review and taxonomy framework mapping quantum technology maturity across clinical domains, but with no primary clinical trial data, patient outcomes, or prospective validation—descriptive synthesis only.